TD Securities (USA)’s Gilead Sciences GILD Stock Holding History

TD Securities (USA)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$28K	Sell	309 -15	-5%	-$1.35K	0.26%	34
2015 Q4	$33K	Sell	324 -515	-61%	-$53.6K	0.3%	27
2015 Q3	$82K	Sell	839 -594,345	-100%	-$66M	0.75%	24
2015 Q2	$69.7M	Buy	595,184 +60,134	+11%	+$6.57M	0.94%	18
2015 Q1	$52.5M	Sell	535,050 -37,840	-7%	-$3.84M	0.79%	24
2014 Q4	$54M	Buy	572,890 +44,124	+8%	+$4.56M	0.77%	26
2014 Q3	$56.3M	Sell	528,766 -8,079	-2%	-$791K	0.91%	20
2014 Q2	$44.5M	Buy	536,845 +32,052	+6%	+$2.49M	0.72%	28
2014 Q1	$35.8M	Sell	504,793 -36,192	-7%	-$2.84M	0.64%	33
2013 Q4	$40.7M	Buy	540,985 +16,920	+3%	+$1.18M	0.68%	32
2013 Q3	$32.9M	Buy	524,065 +3,962	+0.8%	+$237K	0.63%	33
2013 Q2	$26.6M	Buy	+520,103	New	+$27.1M	0.53%	35

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TD Securities (USA)'s GILD Position: Q1 2016 in Review

TD Securities (USA) reduced its Gilead Sciences (GILD) stake by 4.6% in Q1 2016, selling an estimated $1.35K and leaving 309 shares worth $28K. The position accounts for 0.26% of the portfolio, ranked #34.

TD Securities (USA) first reported a position in GILD in Q2 2013 and has held it in 12 quarters since. The position peaked at $69.7M in Q2 2015. 1,630 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

TD Securities (USA) held 309 shares of Gilead Sciences worth $28K as of Q1 2016.
TD Securities (USA) sold 15 Gilead Sciences shares in Q1 2016, an estimated $1.35K.
Gilead Sciences made up 0.26% of TD Securities (USA)'s portfolio in Q1 2016, its #34 holding.
TD Securities (USA) first reported a position in Gilead Sciences in Q2 2013 and has held it in 12 quarters since.
TD Securities (USA)'s Gilead Sciences position peaked at $69.7M in Q2 2015.
1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.